Who Paid My Doc
(OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation
Research payments
$9,113,823
Through program year 2025, $9,113,823 in research payments was reported against (OSPREY)Treating Obstructive Sleep APnea using TaRgetEd HYpoglossal Neurostimulation, across 476 payments, paid by LivaNova USA, Inc..
- Paid by
- LivaNova USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,420,382 | 164 |
| 2024 | Research | $3,922,841 | 132 |
| 2023 | Research | $2,849,087 | 122 |
| 2022 | Research | $921,513 | 58 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Schalch La Mesa, CA Named on 41 payments
- Samuel Mickelson Atlanta, GA Named on 26 payments
- Masayoshi Takashima Houston, TX Named on 18 payments
- Neerav Goyal Hershey, PA Named on 17 payments
- Jose Barrera San Antonio, TX Named on 17 payments
- Randall Ow Roseville, CA Named on 17 payments
- Susheel Patil Baltimore, MD Named on 16 payments
- Edward Mezerhane Miami, FL Named on 16 payments
- Richard Bogan Columbia, SC Named on 16 payments
- Mitchell Miller Clearwater, FL Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.